| Abstrakt: |
The editorial discusses the classification of chronic obstructive pulmonary disease (COPD) severity using spirometry-based systems like GOLD and the newer STAR system. The STAR system, proposed by Bhatt and colleagues, showed differences in mortality risk compared to the GOLD system, particularly in the STAR 1 group. Various studies, including the COPDGene dataset, supported the STAR system's effectiveness in predicting mortality risk, highlighting the need for further research to understand the implications of reclassifying individuals between the two systems. The editorial emphasizes that both systems have their merits, with current treatment decisions in COPD primarily based on symptoms and exacerbation risk rather than airflow limitation severity. [Extracted from the article] |
